Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2011

01.06.2011

The experiences of unpartnered men with prostate cancer: a qualitative analysis

verfasst von: Meredith Wallace Kazer, Janet Harden, Matthew Burke, Martin G. Sanda, Jill Hardy, Donald E. Bailey, PROSTQA Study Group

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to examine how men without partners make decisions about prostate cancer treatment, manage treatment side effects, and obtain information and support.

Background

In 2009, it was projected that over 230,000 men were diagnosed with prostate cancer. While treatment options vary, these options result in changes within the man that can affect his quality of life. Research has shown that often spouses play a central role in men’s choice of treatment and in maintaining men’s quality of life. In addition, spouses are the major providers of emotional support and physical care. However, little is known about how men without partners cope with prostate cancer. Prior research seldom addresses how diagnosis and treatment for prostate cancer affects the quality of life of men without partners.

Methods

Because very little is known about the needs of men without partners managing prostate cancer, qualitative analysis of data obtained during semi-structure interviews provided respondents with an opportunity to share the lived experience of prostate cancer. A semi-structured interview was conducted with selected, consenting men. The sample was drawn from the ongoing R01 study of men with prostate cancer (PROSTQA).

Results

The sample for this study included 17 unpartnered prostate cancer survivors. The ages of participants ranged from 47 to 72 with a mean age of 63. The participants had between zero and two co-morbidities with an average of one co-morbidity per participant. The sample was 82% Caucasian and 17% Black. A total of 35% of the participants reported “some college” (n = 6), 30% graduated from college (n = 5), and 23% went to graduate school (n = 4). One participant reported that he was a high school graduate and one had less than a high school education. Five themes emerged from the data: going it alone, diagnosis and prostate cancer treatment decision-making, sources of information and support, the aftermath of prostate cancer, and coping strategies.

Conclusions

This study provides information about unpartnered men’s prostate cancer experience. This information will help health care professionals to meet the needs of unpartnered more effectively and help them to assist men as they adapt to living with this chronic illness.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2009;59(4):225–49.PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2009;59(4):225–49.PubMedCrossRef
2.
Zurück zum Zitat Litwin MS, Sadetsky N, Pasta DJ, Lubeck DP. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J Urol. 2004;172:515–9.PubMedCrossRef Litwin MS, Sadetsky N, Pasta DJ, Lubeck DP. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J Urol. 2004;172:515–9.PubMedCrossRef
3.
Zurück zum Zitat Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Katttan MW, Carroll PR, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004;171:703–8.PubMedCrossRef Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Katttan MW, Carroll PR, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004;171:703–8.PubMedCrossRef
4.
Zurück zum Zitat Hedestig O, Sandman P, Tomic R, Widmark A. Living after external beam radiotherapy of localized prostate cancer. Cancer Nurs. 2005;28(4):310–7.PubMedCrossRef Hedestig O, Sandman P, Tomic R, Widmark A. Living after external beam radiotherapy of localized prostate cancer. Cancer Nurs. 2005;28(4):310–7.PubMedCrossRef
5.
Zurück zum Zitat Ward-Smith P, Kapitan D. Quality of life among men treated with radiation therapy for prostate cancer. Urol Nurs. 2005;25(4):263–8.PubMed Ward-Smith P, Kapitan D. Quality of life among men treated with radiation therapy for prostate cancer. Urol Nurs. 2005;25(4):263–8.PubMed
6.
Zurück zum Zitat Novan L, Morag A. Advanced prostate cancer patients’ relationships with their spouses following hormonal therapy. Eur J Oncol Nurs. 2003;7:73–80.CrossRef Novan L, Morag A. Advanced prostate cancer patients’ relationships with their spouses following hormonal therapy. Eur J Oncol Nurs. 2003;7:73–80.CrossRef
7.
Zurück zum Zitat Harden J, Schafenacker A, Northouse LL, Mood D, Smith D, Pienta K, et al. Couples’ experiences with prostate cancer: focus group research. Oncol Nurs Forum. 2002;29(4):701–9.PubMedCrossRef Harden J, Schafenacker A, Northouse LL, Mood D, Smith D, Pienta K, et al. Couples’ experiences with prostate cancer: focus group research. Oncol Nurs Forum. 2002;29(4):701–9.PubMedCrossRef
8.
Zurück zum Zitat Harden J, Northouse LL, Mood D. Qualitative analysis of couples’ experience with prostate cancer by age cohort. Cancer Nurs. 2006;29(5):367–77.PubMedCrossRef Harden J, Northouse LL, Mood D. Qualitative analysis of couples’ experience with prostate cancer by age cohort. Cancer Nurs. 2006;29(5):367–77.PubMedCrossRef
9.
Zurück zum Zitat Maliski SL, Heilemann MV, McCorkle R. From “death sentence” to “good cancer”: couples’ transformation of a prostate cancer diagnosis. Nurs Res. 2002;51(6):391–7.PubMedCrossRef Maliski SL, Heilemann MV, McCorkle R. From “death sentence” to “good cancer”: couples’ transformation of a prostate cancer diagnosis. Nurs Res. 2002;51(6):391–7.PubMedCrossRef
10.
Zurück zum Zitat Jakobsson L, Hallberg IR, Loven L. Experiences of daily life and life quality in men with prostate cancer: an exploratory study. Part 1. Eur J Cancer Care. 1997;6:108–11.CrossRef Jakobsson L, Hallberg IR, Loven L. Experiences of daily life and life quality in men with prostate cancer: an exploratory study. Part 1. Eur J Cancer Care. 1997;6:108–11.CrossRef
13.
Zurück zum Zitat Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996;156(5):1696–1700.PubMedCrossRef Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996;156(5):1696–1700.PubMedCrossRef
14.
Zurück zum Zitat Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer. 2005;103(9):1819–25.PubMedCrossRef Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer. 2005;103(9):1819–25.PubMedCrossRef
15.
Zurück zum Zitat Perczek RE, Burke MA, Carver CS, Krongrad A, Terris MK. Facing a prostate cancer diagnosis: who is at risk for increased distress? Cancer. 2002;94(11):2923–9.PubMedCrossRef Perczek RE, Burke MA, Carver CS, Krongrad A, Terris MK. Facing a prostate cancer diagnosis: who is at risk for increased distress? Cancer. 2002;94(11):2923–9.PubMedCrossRef
16.
Zurück zum Zitat Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.PubMedCrossRef Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.PubMedCrossRef
17.
Zurück zum Zitat Newell GR, Pollack ES, Spitz MR, Sider JG, Fueger JJ. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987;79(2):259–62.PubMed Newell GR, Pollack ES, Spitz MR, Sider JG, Fueger JJ. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987;79(2):259–62.PubMed
19.
Zurück zum Zitat Korfage IJ, de Koning HJ, Roobol M, Schroder FH, Essink-Bot ML. Prostate cancer diagnosis: the impact on patients’ mental health. Eur J Cancer. 2006;42(2):165–70.PubMedCrossRef Korfage IJ, de Koning HJ, Roobol M, Schroder FH, Essink-Bot ML. Prostate cancer diagnosis: the impact on patients’ mental health. Eur J Cancer. 2006;42(2):165–70.PubMedCrossRef
20.
Zurück zum Zitat Ben-Tovim DI, Dougherty MLG, Stapleton AMF, Pinnock CB. Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument. Urology. 2002;59(3):383–8. doi:10.1016/S0090-4295(01)01540-0.PubMedCrossRef Ben-Tovim DI, Dougherty MLG, Stapleton AMF, Pinnock CB. Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument. Urology. 2002;59(3):383–8. doi:10.​1016/​S0090-4295(01)01540-0.PubMedCrossRef
21.
Zurück zum Zitat Thaxton L, Emshoff JG, Guessous O. Prostate cancer support groups: literature review. J Psychosoc Oncol. 2005;23(1):25–40.PubMedCrossRef Thaxton L, Emshoff JG, Guessous O. Prostate cancer support groups: literature review. J Psychosoc Oncol. 2005;23(1):25–40.PubMedCrossRef
23.
Zurück zum Zitat Crighton FL. University Kansas research paper. 2002. p. 165. Crighton FL. University Kansas research paper. 2002. p. 165.
24.
Zurück zum Zitat Harden J, Schafenacker A, Northouse L, Mood D, Pienta K, Hussain M, et al. Couples experiences with prostate cancer: focus group research. Oncol Nurs Forum. 2002;29:701–9.PubMedCrossRef Harden J, Schafenacker A, Northouse L, Mood D, Pienta K, Hussain M, et al. Couples experiences with prostate cancer: focus group research. Oncol Nurs Forum. 2002;29:701–9.PubMedCrossRef
25.
Zurück zum Zitat Lintz K, Moynihan C, Steginga S, Norman A, Eeles K, Huddart R, Dearnaley D, Watson NM. Prostate cancer patient’s support and psychological care needs: Survey from a Non-Surgical Oncology Clinic. 2002; 50 Lintz K, Moynihan C, Steginga S, Norman A, Eeles K, Huddart R, Dearnaley D, Watson NM. Prostate cancer patient’s support and psychological care needs: Survey from a Non-Surgical Oncology Clinic. 2002; 50
26.
Zurück zum Zitat Wallace M, Storms S. The needs of men with prostate cancer. Appl Nurs Res. 2007;20(4):181–7.PubMedCrossRef Wallace M, Storms S. The needs of men with prostate cancer. Appl Nurs Res. 2007;20(4):181–7.PubMedCrossRef
27.
Zurück zum Zitat Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care. 2001;10 Suppl 1:34–8. Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care. 2001;10 Suppl 1:34–8.
28.
Zurück zum Zitat Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2004;140:54–9.PubMed Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2004;140:54–9.PubMed
30.
Zurück zum Zitat Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–8.PubMedCrossRef Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–8.PubMedCrossRef
32.
Zurück zum Zitat Broom A. The eMale: prostate cancer, masculinity and online support as a challenge to medical expertise. J Sociol. 2005;41(1):87–104.CrossRef Broom A. The eMale: prostate cancer, masculinity and online support as a challenge to medical expertise. J Sociol. 2005;41(1):87–104.CrossRef
33.
Zurück zum Zitat Smither AR, Guralnick ML, Davis NB, See WA. Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. BMC Urology. 2007; 7(2) Smither AR, Guralnick ML, Davis NB, See WA. Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. BMC Urology. 2007; 7(2)
34.
Zurück zum Zitat Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001;165(2):430–5.PubMedCrossRef Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001;165(2):430–5.PubMedCrossRef
35.
Zurück zum Zitat Yoshioka Y. Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol. 2009;14:31–6.PubMedCrossRef Yoshioka Y. Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol. 2009;14:31–6.PubMedCrossRef
36.
Zurück zum Zitat Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234–47.PubMed Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234–47.PubMed
Metadaten
Titel
The experiences of unpartnered men with prostate cancer: a qualitative analysis
verfasst von
Meredith Wallace Kazer
Janet Harden
Matthew Burke
Martin G. Sanda
Jill Hardy
Donald E. Bailey
PROSTQA Study Group
Publikationsdatum
01.06.2011
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2011
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0157-3

Weitere Artikel der Ausgabe 2/2011

Journal of Cancer Survivorship 2/2011 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.